Showing results (1901-1910 of 2,139) with videos related to
Sort By:
Pageof 214
JAMA|August 9, 2013
Risk factors associated with suicide in current and former US military personnelCynthia A LeardMann, Teresa M Powell, Tyler C Smith, et al.Pathogens (Basel, Switzerland)|December 19, 2019
Effects of <i>Pseudomonas aeruginosa</i> on Microglial-Derived Extracellular Vesicle Biogenesis and CompositionLeandra B Jones, Sanjay Kumar, Courtnee' R Bell, et al.Circulation. Heart Failure|February 16, 2020
Regional Variation in the Management and Outcomes of Acute Myocardial Infarction With Cardiogenic Shock in the United StatesSaraschandra Vallabhajosyula, Sri Harsha Patlolla, Shannon M Dunlay, et al.Geroscience|July 18, 2022
Aging alters antiviral signaling pathways resulting in functional impairment in innate immunity in response to pattern recognition receptor agonistsJennifer Connors, Bhavani Taramangalam, Gina Cusimano, et al.Free Radical Biology & Medicine|November 1, 1992
Breath ethane: a specific indicator of free-radical-mediated lipid peroxidation following reperfusion of the ischemic liverM Kazui, K A Andreoni, E J Norris, et al.Nature Communications|April 20, 2022
Chemotherapy-induced COX-2 upregulation by cancer cells defines their inflammatory properties and limits the efficacy of chemoimmunotherapy combinationsCharlotte R Bell, Victoria S Pelly, Agrin Moeini, et al.European Heart Journal|January 25, 2013
Long-term outcomes of fractional flow reserve-guided vs. angiography-guided percutaneous coronary intervention in contemporary practiceJing Li, Muhamad Y Elrashidi, Andreas J Flammer, et al.Journal of the American College of Cardiology|December 10, 1999
Clopidogrel versus ticlopidine after intracoronary stent placementP B Berger, M R Bell, C S Rihal, et al.British Medical Journal (Clinical Research Ed.)|April 24, 1982
Short-term treatment for acute myelogenous leukaemiaR Bell, A Z Rohatiner, M L Slevin, et al.Circulation|May 6, 1997
Randomized, double-blind, placebo-controlled study evaluating the efficacy and safety of AS-013, a prostaglandin E1 prodrug, in patients with intermittent claudicationJ J Belch, P R Bell, D Creissen, et al.Pageof 214